Differential clinicopathologic and genetic features of late-onset amnestic dementias

Acta Neuropathologica

Volumn 128, Issue 3, 2014, Pages 411-421

  Murray, Melissa E ^a   Cannon, Ashley ^a   Graff Radford, Neill R ^b   Liesinger, Amanda M ^a   Rutherford, Nicola J ^a   Ross, Owen A ^a   Duara, Ranjan ^c   Carrasquillo, Minerva M ^a   Rademakers, Rosa ^a   Dickson, Dennis W ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; APOE; GRN; Hippocampal sclerosis; Neurofibrillary tangles; Neuropathology; TDP 43; TMEM106B

Indexed keywords

TAR DNA BINDING PROTEIN; APOLIPOPROTEIN E; DNA BINDING PROTEIN; GRN PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN; PROTEIN TDP-43; SIGNAL PEPTIDE; TMEM106B PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; AMNESTIC DEMENTIA; ARTICLE; AUTOPSY; CLINICAL FEATURE; COHORT ANALYSIS; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; FEMALE; FRONTOTEMPORAL DEMENTIA; GENETIC ANALYSIS; GENETIC VARIABILITY; HIPPOCAMPAL SCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; TDP 43 PROTEINOPATHY; AGING; AMYLOID PLAQUE; CLASSIFICATION; COGNITION DISORDERS; DNA MUTATIONAL ANALYSIS; GENETICS; HIPPOCAMPUS; LONGITUDINAL STUDY; NEUROFIBRILLARY TANGLE; NEUROPSYCHOLOGICAL TEST; NONPARAMETRIC TEST; PATHOLOGY; SCLEROSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COGNITION DISORDERS; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; HIPPOCAMPUS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LONGITUDINAL STUDIES; MALE; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NEUROFIBRILLARY TANGLES; NEUROPSYCHOLOGICAL TESTS; PLAQUE, AMYLOID; SCLEROSIS; STATISTICS, NONPARAMETRIC;

EID: 84906317716     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1302-2     Document Type: Article

References (36)

1. Alladi S, Xuereb J, Bak T, Nestor P, Knibb J, Patterson K, Hodges JR (2007) Focal cortical presentations of Alzheimer's disease. Brain 130:2636-2645. doi:10.1093/brain/awm213 (Pubitemid 47511719)
2. Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61:435-445. doi:10.1002/ana.21154 (Pubitemid 46878771)
3. Arai T, Mackenzie IR, Hasegawa M, Nonoka T, Niizato K, Tsuchiya K, Iritani S, Onaya M, Akiyama H (2009) Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 117:125-136. doi:10.1007/s00401-008-0480-1
4. Attems J, Jellinger KA (2006) Hippocampal sclerosis in Alzheimer disease and other dementias. Neurology 66:775. doi:10.1212/01.wnl.0000200959.50898.26 (pii):66/5/775
5. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
6. Brenowitz WD, Monsell SE, Schmitt FA, Kukull WA, Nelson PT (2014) Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both Alzheimer's disease and non-tauopathic frontotemporal lobar degeneration. J Alzheimers Dis 39:691-702. doi:10.3233/JAD-131880Q123N6P2Q0511V80
7. Davidson YS, Raby S, Foulds PG, Robinson A, Thompson JC, Sikkink S, Yusuf I, Amin H, DuPlessis D, Troakes C, Al-Sarraj S, Sloan C, Esiri MM, Prasher VP, Allsop D, Neary D, Pickering-Brown SM, Snowden JS, Mann DM (2011) TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 122:703-713. doi:10.1007/s00401-011-0879-y
8. Deming Y, Cruchaga C (2014) TMEM106B: a strong FTLD disease modifier. Acta Neuropathol 127:419-422. doi:10.1007/s00401-014-1249-3
9. Dickson DW, Baker M, Rademakers R (2010) Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegener Dis 7:170-174. doi:10.1159/000289231
10. Dickson DW, Davies P, Bevona C, Van Hoeven KH, Factor SM, Grober E, Aronson MK, Crystal HA (1994) Hippocampal sclerosis: a common pathological feature of dementia in very old (>or = 80 years of age) humans. Acta Neuropathol 88:212-221 (Pubitemid 24265424)
11. Finch N, Carrasquillo MM, Baker M, Rutherford NJ, Coppola G, Dejesus-Hernandez M, Crook R, Hunter T, Ghidoni R, Benussi L, Crook J, Finger E, Hantanpaa KJ, Karydas AM, Sengdy P, Gonzalez J, Seeley WW, Johnson N, Beach TG, Mesulam M, Forloni G, Kertesz A, Knopman DS, Uitti R, White CL 3rd, Caselli R, Lippa C, Bigio EH, Wszolek ZK, Binetti G, Mackenzie IR, Miller BL, Boeve BF, Younkin SG, Dickson DW, Petersen RC, Graff-Radford NR, Geschwind DH, Rademakers R (2011) TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology 76:467-474. doi:10.1212/WNL.0b013e31820a0e3b
12. Fotuhi M, Do D, Jack C (2012) Modifiable factors that alter the size of the hippocampus with ageing. Nat Rev Neurol 8:189-202. doi:10.1038/nrneurol. 2012.27
13. Gallagher M, Suh E, Grossman M, Elman L, McCluskey L, Swieten J, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer J, Halliday G, Broeckhoven C, Seilhean D, Shaw P, Frosch M, Alafuzoff I, Antonell A, Bogdanovic N, Brooks W, Cairns N, Cooper-Knock J, Cotman C, Cras P, Cruts M, Deyn P, DeCarli C, Dobson-Stone C, Engelborghs S, Fox N, Galasko D, Gearing M, Gijselinck I, Grafman J, Hartikainen P, Hatanpaa K, Highley JR, Hodges J, Hulette C, Ince P, Jin L-W, Kirby J, Kofler J, Kril J, Kwok JJ, Levey A, Lieberman A, Llado A, Martin J-J, Masliah E, McDermott C, McKee A, McLean C, Mead S, Miller C, Miller J, Munoz D, Murrell J, Paulson H, Piguet O, Rossor M, Sanchez-Valle R, Sano M, Schneider J, Silbert L, Spina S, Zee J, Langenhove T, Warren J, Wharton S, White Iii C, Woltjer R, Trojanowski J, Lee VY, Deerlin V, Chen-Plotkin A (2014) TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol 127:407-418. doi:10.1007/s00401-013-1239-x
14. Galton CJ, Patterson K, Xuereb JH, Hodges JR (2000) Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123(Pt 3):484-498 (Pubitemid 30099534)
15. Graff-Radford NR, Murray ME, Ross OA, Duara R, Rademakers R, Whitwell JL, Dickson DW (2012) Differentiating clinicopathologic and genetic aspects of hippocampal sclerosis in Alzheimer's disease from limbic predominant Alzheimer's disease and "pure" hippocampal sclerosis. Alzheimer's Dement 8:P620-P621
16. Hyman BT, Trojanowski JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095-1097
17. Janocko NJ, Brodersen KA, Soto-Ortolaza AI, Ross OA, Liesinger AM, Duara R, Graff-Radford NR, Dickson DW, Murray ME (2012) Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia. Acta Neuropathol 124:681-692. doi:10.1007/s00401- 012-1044-y
18. Jellinger KA, Attems J (2003) Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study. Acta Neuropathol 105:14-17. doi:10.1007/s00401-002-0634-5 (Pubitemid 36789951)
19. Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N, Liesinger AM, Petrucelli L, Senjem ML, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Jack CR, Jr, Parisi JE, Petersen RC, Dickson DW (2014) TDP-43 is a key player in the clinical features associated with Alzheimer's disease. Acta Neuropathol. doi:10.1007/s00401-014-1269-z
20. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42:1097-1105
21. Lee MJ, Chen TF, Cheng TW, Chiu MJ (2011) rs5848 variant of progranulin gene is a risk of Alzheimer's disease in the Taiwanese population. Neurodegener Dis 8:216-220. doi:10.1159/000322538
22. Leverenz JB, Agustin CM, Tsuang D, Peskind ER, Edland SD, Nochlin D, DiGiacomo L, Bowen JD, McCormick WC, Teri L, Raskind MA, Kukull WA, Larson EB (2002) Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study. Arch Neurol 59:1099-1106 noc10247
23. Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011) Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 10:785-796. doi:10.1016/ S1474-4422(11)70156-9
24. Nelson P, Smith C, Abner E, Wilfred B, Wang W-X, Neltner J, Baker M, Fardo D, Kryscio R, Scheff S, Jicha G, Jellinger K, Eldik L, Schmitt F (2013) Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol 126:161-177. doi:10.1007/s00401-013-1154-1
25. Nelson PT, Abner EL, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Davis DG, Poduska JW, Patel E, Mendiondo MS, Markesbery WR (2010) Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol 20:66-79. doi:10.1111/j.1750-3639.2008.00244.xBPA244
26. Nelson PT, Estus S, Abner EL, Parikh I, Malik M, Neltner JH, Ighodaro E, Wang WX, Wilfred BR, Wang LS, Kukull WA, Nandakumar K, Farman ML, Poon WW, Corrada MM, Kawas CH, Cribbs DH, Bennett DA, Schneider JA, Larson EB, Crane PK, Valladares O, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Scheff SW, Sonnen JA, Haines JL, Pericak-Vance MA, Mayeux R, Farrer LA, Van Eldik LJ, Horbinski C, Green RC, Gearing M, Poon LW, Kramer PL, Woltjer RL, Montine TJ, Partch AB, Rajic AJ, Richmire K, Monsell SE, Schellenberg GD, Fardo DW (2014) ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol. doi:10.1007/s00401-014-1282-2
27. Nelson PT, Schmitt FA, Lin Y, Abner EL, Jicha GA, Patel E, Thomason PC, Neltner JH, Smith CD, Santacruz KS, Sonnen JA, Poon LW, Gearing M, Green RC, Woodard JL, Van Eldik LJ, Kryscio RJ (2011) Hippocampal sclerosis in advanced age: clinical and pathological features. Brain 134:1506-1518. doi:10.1093/brain/awr053
28. Neltner JH, Abner EL, Baker S, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Hammack E, Kukull WA, Brenowitz WD, Van Eldik LJ, Nelson PT (2014) Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain 137:255-267. doi:10.1093/brain/awt318
29. Pao WC, Dickson DW, Crook JE, Finch NA, Rademakers R, Graff-Radford NR (2011) Hippocampal sclerosis in the elderly: genetic and pathologic findings, some mimicking Alzheimer disease clinically. Alzheimer Dis Assoc Disord 25:364-368. doi:10.1097/WAD.0b013e31820f8f50
30. Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ, Finch N, Rutherford NJ, Crook RJ, Josephs KA, Boeve BF, Knopman DS, Petersen RC, Parisi JE, Caselli RJ, Wszolek ZK, Uitti RJ, Feldman H, Hutton ML, Mackenzie IR, Graff-Radford NR, Dickson DW (2008) Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 17:3631-3642. doi:10.1093/hmg/ddn257
31. Rauramaa T, Pikkarainen M, Englund E, Ince PG, Jellinger K, Paetau A, Alafuzoff I (2013) Consensus recommendations on pathologic changes in the hippocampus: a postmortem multicenter inter-rater study. J Neuropathol Exp Neurol 72(452-461):4. doi:10.1097/NEN.1090b1013e318292492a
32. Rutherford NJ, Carrasquillo MM, Li M, Bisceglio G, Menke J, Josephs KA, Parisi JE, Petersen RC, Graff-Radford NR, Younkin SG, Dickson DW, Rademakers R (2012) TMEM106B risk variant is implicated in the pathologic presentation of Alzheimer disease. Neurology 79:717-718. doi:10.1212/WNL.0b013e318264e3ac
33. Troncoso JC, Kawas CH, Chang CK, Folstein MF, Hedreen JC (1996) Lack of association of the apoE4 allele with hippocampal sclerosis dementia. Neurosci Lett 204:138-140 (Pubitemid 26053688)
34. Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685-697. doi:10.1097/01.jnen.0000225908.90052.07 (Pubitemid 44297259)
35. van Blitterswijk M, Mullen B, Nicholson A, Bieniek K, Heckman M, Baker M, DeJesus-Hernandez M, Finch N, Brown P, Murray M, Hsiung G-Y, Stewart H, Karydas A, Finger E, Kertesz A, Bigio E, Weintraub S, Mesulam M, Hatanpaa K, White Iii C, Strong M, Beach T, Wszolek Z, Lippa C, Caselli R, Petrucelli L, Josephs K, Parisi J, Knopman D, Petersen R, Mackenzie I, Seeley W, Grinberg L, Miller B, Boylan K, Graff-Radford N, Boeve B, Dickson D, Rademakers R (2014) TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathol 127:397-406. doi:10.1007/s00401-013-1240-4
36. Viswanathan J, Makinen P, Helisalmi S, Haapasalo A, Soininen H, Hiltunen M (2009) An association study between granulin gene polymorphisms and Alzheimer's disease in Finnish population. Am J Med Genet B Neuropsychiatr Genet 150B:747-750. doi:10.1002/ajmg.b.30889